Development and Optimization of Memantine-PEGylated PLGA Liposomal Formulation for Nose-to-Brain Delivery in Alzheimer's Disease: A Quality-by-Design (QbD) Approach
Indian Journal of Pharmaceutical Education and Research · 23.04.2026 · 60 (3) · 999-1012
DOI: 10.5530/ijper.20261979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.04.2026. Verfasst von Abhish Jadhav und 1 weiteren Autor:innen.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jadhav, A., & Bele, M. (2026). Development and Optimization of Memantine-PEGylated PLGA Liposomal Formulation for Nose-to-Brain Delivery in Alzheimer's Disease: A Quality-by-Design (QbD) Approach. Indian Journal of Pharmaceutical Education and Research, 60(3), 999-1012. https://doi.org/10.5530/ijper.20261979
Vancouver
Jadhav A, Bele M. Development and Optimization of Memantine-PEGylated PLGA Liposomal Formulation for Nose-to-Brain Delivery in Alzheimer's Disease: A Quality-by-Design (QbD) Approach. Indian Journal of Pharmaceutical Education and Research. 2026;60(3):999-1012. doi:10.5530/ijper.20261979
BibTeX
@article{Jadhav2026,
author = {Jadhav, Abhish and Bele, Mrudula},
title = {Development and Optimization of Memantine-PEGylated PLGA Liposomal Formulation for Nose-to-Brain Delivery in Alzheimer's Disease: A Quality-by-Design (QbD) Approach},
journal = {Indian Journal of Pharmaceutical Education and Research},
year = {2026},
volume = {60},
number = {3},
pages = {999--1012},
doi = {10.5530/ijper.20261979}
}
EUVIMED